Dr Reddys Laboratories (RDY) Sales of Property, Plant and Equipment (2009 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Sales of Property, Plant and Equipment (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.60 Bn | 38.94 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.15 Bn | 18.27 Bn | 1.46 Bn | 8.20 Mn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 3.76 Mn |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.35 Bn | 516.55 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 996.17 Mn | 706.05 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 404.39 Mn | 363.15 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.76 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 373,910.77 |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 638,202.12 |
| Dec 31, 2023 | 6.29 Mn |
| Sep 30, 2023 | 5.66 Mn |
| Jun 30, 2023 | 231,261.59 |
| Mar 31, 2023 | 316,286.16 |
| Dec 31, 2022 | 97,439.41 |
| Sep 30, 2022 | -1.64 Mn |
| Jun 30, 2022 | 2.32 Mn |
| Mar 31, 2022 | 2.38 Mn |
| Dec 31, 2021 | 493,824.07 |
| Sep 30, 2021 | 1.44 Mn |
| Jun 30, 2021 | 637,410.52 |
| Mar 31, 2021 | 397,731.40 |
| Dec 31, 2020 | 311,408.66 |
| Sep 30, 2020 | 402,803.08 |